Company Performance: Revenue, profit margins, and earnings per share directly impact investor confidence and stock valuation.

Industry Trends: The overall health and growth prospects of the pharmaceutical industry, particularly vaccines, influence stock performance.

Regulatory Environment: Government regulations, drug approvals, and healthcare policies can significantly affect revenue streams and market access.

Market Sentiment: General investor optimism or pessimism, as well as broader economic conditions, impacts trading volumes and stock prices.

Competition: The presence and performance of competing pharmaceutical companies influence market share and profitability.

News & Announcements: Positive or negative press releases, product launches, and clinical trial results create price volatility.

Global Health Events: Pandemics and disease outbreaks create demand and drive vaccine-related stock prices higher.

Technological Advancements: Breakthroughs in vaccine technology and drug development could impact the company's competitive advantage and valuation.